A Phase 3 Study of Etelcalceide in Pediatric Subjects With Secondary Hyperparathyroidism and CKD on Hemodialysis.
Conditions: Secondary Hyperparathyroidism; Chronic Kidney Disease Intervention: Drug: Etelcalcetide Sponsor: Amgen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Dialysis | Hemodialysis | Hyperparathyroidism | Pediatrics | Study | Urology & Nephrology